Ischemia or ischaemia is a restriction in blood supply to any tissues, muscle group, or organ of the body, causing a shortage of oxygen that is needed for cellular metabolism (to keep tissue alive). Ischemia is generally caused by problems with blood vessels, with resultant damage to or dysfunction of tissue i.e. hypoxia and microvascular dysfunction. It also means local hypoxia in a given part of a body sometimes resulting from constriction (such as vasoconstriction, thrombosis or embolism). Ischemia comprises not only insufficiency of oxygen, but also reduced availability of nutrients and inadequate removal of metabolic wastes. Ischemia can be partial (poor perfusion) or total blockage. The inadequate delivery of oxygenated blood to the organs must be resolved either by treating the cause of the inadequate delivery or reducing the oxygen demand of the system that needs it. For example, patients with myocardial ischemia have a decreased blood flow to the heart and are prescribed with medications that reduce chronotrophy and ionotrophy to meet the new level of blood delivery supplied by the stenosed so that it is adequate.
Signs and symptoms
The signs and symptoms of ischemia vary, as it can occur anywhere in the body and depends on the degree to which blood flow is interrupted. For example, clinical manifestations of acute limb ischemia (which can be summarized as the "six P's") include pain, pallor, pulseless, paresthesia, paralysis, and poikilothermia.
Without immediate intervention, ischemia may progress quickly to tissue necrosis and gangrene within a few hours. Paralysis is a very late sign of acute arterial ischemia and signals the death of nerves supplying the extremity. Foot drop may occur as a result of nerve damage. Because nerves are extremely sensitive to hypoxia, limb paralysis or ischemic neuropathy may persist after revascularization and may be permanent.
Cardiac ischemia may be asymptomatic or may cause chest pain, known as angina pectoris. It occurs when the heart muscle, or myocardium, receives insufficient blood flow. This most frequently results from atherosclerosis, which is the long-term accumulation of cholesterol-rich plaques in the coronary arteries. In most Western countries, Ischemic heart disease is the most common cause of death in both men and women, and a major cause of hospital admissions.
Both large and small intestines can be affected by ischemia. The blockage of blood flow to the large intestine (colon) is called ischemic colitis. Ischemia of the small bowel is called mesenteric ischemia.
Brain ischemia is insufficient blood flow to the brain, and can be acute or chronic. Acute ischemic stroke is a neurological emergency typically caused by a blood clot blocking blood flow in a vessel in the brain. Chronic ischemia of the brain may result in a form of dementia called vascular dementia. A sudden, brief episode (symptoms lasting only minutes) of ischemia affecting the brain is called a transient ischemic attack (TIA), often called a mini-stroke. TIAs can be a warning of future strokes, with approximately 1/3 of TIA patients having a serious stroke within one year.
Reduced blood flow to the skin layers may result in mottling or uneven, patchy discoloration of the skin.
Kidney Ischemia is a loss of blood flow to the kidney cells. Several physical symptoms include shrinkage of one or both kidneys, renovascular hypertension, acute renal failure, progressive azotemia, and acute pulmonary edema. It is a disease with high mortality rate and high morbidity. Failure to treat could cause chronic kidney disease and a need for renal surgery.
Ischemia is a vascular disease involving an interruption in the arterial blood supply to a tissue, organ, or extremity that, if untreated, can lead to tissue death. It can be caused by embolism, thrombosis of an atherosclerotic artery, or trauma. Venous problems like venous outflow obstruction and low-flow states can cause acute arterial ischemia. An aneurysm is one of the most frequent causes of acute arterial ischemia. Other causes are heart conditions including myocardial infarction, mitral valve disease, chronic atrial fibrillation, cardiomyopathies, and prosthesis, in all of which thrombi are prone to develop.
The thrombi may dislodge and may travel anywhere in the circulatory system, where they may lead to pulmonary embolus, an acute arterial occlusion causing the oxygen and blood supply distal to the embolus to decrease suddenly. The degree and extent of symptoms depend on the size and location of the obstruction, the occurrence of clot fragmentation with embolism to smaller vessels, and the degree of peripheral arterial disease (PAD).
- Thromboembolism (blood clots)
- Embolism (foreign bodies in the circulation, e.g. amniotic fluid embolism)
Traumatic injury to an extremity may produce partial or total occlusion of a vessel from compression, shearing, or laceration. Acute arterial occlusion may develop as a result of arterial dissection in the carotid artery or aorta or as a result of iatrogenic arterial injury (e.g., after angiography).
An inadequate flow of blood to a part of the body may be caused by any of the following:
- Thoracic outlet syndrome (compression of the brachial plexus)
- Atherosclerosis (lipid-laden plaques obstructing the lumen of arteries)
- Hypoglycemia (lower than normal level of glucose)
- Tachycardia (abnormally rapid beating of the heart)
- Hypotension (low blood pressure, e.g. in septic shock, heart failure)
- Outside compression of a blood vessel, e.g. by a tumor or in the case of superior mesenteric artery syndrome
- Sickle cell disease (abnormally shaped red blood cells)
- Induced g-forces which restrict the blood flow and force the blood to the extremities of the body, as in acrobatics and military flying
- Localized extreme cold, such as by frostbite or improper cold compression therapy
- Tourniquet application
- An increased level of glutamate receptor stimulation 
- Arteriovenous malformations and peripheral artery occlusive disease
- rupture of significant blood vessels supplying a tissue or organ.
- Anemia vasoconstricts the periphery so that red blood cells can work internally on vital organs such as the heart, brain, etc., thus causing lack of oxygen to the periphery.
- Premature discontinuation of any oral anticoagulant.
- Unconsciousness, such as due to the ingestion of excessive doses of central depressants like alcohol or opioids, can result in ischemia of the extremities due to unusual body positions that prevent normal circulation
Ischemia results in tissue damage in a process known as ischemic cascade. The damage is the result of the build-up of metabolic waste products, inability to maintain cell membranes, mitochondrial damage, and eventual leakage of autolyzing proteolytic enzymes into the cell and surrounding tissues.
Restoration of blood supply to ischemic tissues can cause additional damage known as reperfusion injury that can be more damaging than the initial ischemia. Reintroduction of blood flow brings oxygen back to the tissues, causing a greater production of free radicals and reactive oxygen species that damage cells. It also brings more calcium ions to the tissues causing further calcium overloading and can result in potentially fatal cardiac arrhythmias and also accelerates cellular self-destruction. The restored blood flow also exaggerates the inflammation response of damaged tissues, causing white blood cells to destroy damaged cells that may otherwise still be viable.
Early treatment is essential to keep the affected organ viable. The treatment options include injection of an anticoagulant, thrombolysis, embolectomy, surgical revascularization, or partial amputation. Anticoagulant therapy is initiated to prevent further enlargement of the thrombus. Continuous IV unfractionated heparin has been the traditional agent of choice.
If the condition of the ischemic limb is stabilized with anticoagulation, recently formed emboli may be treated with catheter-directed thrombolysis using intra-arterial infusion of a thrombolytic agent (e.g., recombinant tissue plasminogen activator (tPA), streptokinase, or urokinase). A percutaneous catheter inserted into the femoral artery and threaded to the site of the clot is used to infuse the drug. Unlike anticoagulants, thrombolytic agents work directly to resolve the clot over a period of 24 to 48 hours.
Direct arteriotomy may be necessary to remove the clot. Surgical revascularization may be used in the setting of trauma (e.g., laceration of the artery). Amputation is reserved for cases where limb salvage is not possible. If the patient continues to have a risk of further embolization from some persistent source, such as chronic atrial fibrillation, treatment includes long-term oral anticoagulation to prevent further acute arterial ischemic episodes.
Decrease in body temperature reduces the aerobic metabolic rate of the affected cells, reducing the immediate effects of hypoxia. Reduction of body temperature also reduces the inflammation response and reperfusion injury. For frostbite injuries, limiting thawing and warming of tissues until warmer temperatures can be sustained may reduce reperfusion injury.
Society and culture
Etymology and pronunciation
- Inhibitor protein
- Trauma triad of death
- Ischemia-reperfusion injury of the appendicular musculoskeletal system
- OED 2nd edition, 1989.
- Entry "ischemia" in Merriam-Webster Online Dictionary.
- Merck & Co. Occlusive Peripheral Arterial Disease, The Merck Manual Home Health Handbook website, revised and updated March 2010. Retrieved March 4, 2012.
- "Chronic Limb-Threatening Ischemia (CLTI) – Vascular Cures". Retrieved 2021-10-27.
- Zhai Y, Petrowsky H, Hong JC, et al: Ischaemia-reperfusion injury in liver transplantation—From bench to bedside. Nat Rev Gastroenterol Hepatol 2013; 10:79–89
- Perico N, Cattaneo D, Sayegh MH, et al: Delayed graft function in kidney transplantation. Lancet 2004; 364:1814–1827
- Smith, David A.; Lilie, Craig J. (2021), "Acute Arterial Occlusion", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 28722881, retrieved 2021-10-27
- Lewis. S.L (2008). Medical-Surgical Nursing (7th ed.). Vascular disorder. pp. 907–908.
- "Myocardial ischemia - Symptoms and causes". Mayo Clinic. Retrieved 2021-10-27.
- World Health Organization Department of Health Statistics and Informatics in the Information, Evidence and Research Cluster (2004). The global burden of disease 2004 update. Geneva: WHO. ISBN 92-4-156371-0.
- "Coronary Artery Disease". medlineplus.gov. Retrieved 2021-10-27.
- "Ischemic colitis - Symptoms and causes". Mayo Clinic. Retrieved 2021-10-27.
- "Acute Mesenteric Ischemia - Digestive Disorders". Merck Manuals Consumer Version. Retrieved 2021-10-27.
- "Ischemic Stroke". medlineplus.gov. Retrieved 2021-10-27.
- Kuźma, Elżbieta; Lourida, Ilianna; Moore, Sarah F.; Levine, Deborah A.; Ukoumunne, Obioha C.; Llewellyn, David J. (August 2018). "Stroke and dementia risk: A systematic review and meta-analysis". Alzheimer's & Dementia. 14 (11): 1416–1426. doi:10.1016/j.jalz.2018.06.3061. hdl:2027.42/152961. ISSN 1552-5260. PMC 6231970. PMID 30177276.
- "Transient Ischemic Attack". medlineplus.gov. Retrieved 2021-10-27.
- "What is a TIA". www.stroke.org. Retrieved 2021-10-27.
- "Ischemic renal disease: an emerging cause of chronic renal... : Journal of Hypertension". LWW. Retrieved 2020-12-20.
- "Renovascular hypertension: MedlinePlus Medical Encyclopedia". medlineplus.gov. Retrieved 2020-12-20.
- Sharfuddin, Asif A.; Molitoris, Bruce A. (April 2011). "Pathophysiology of ischemic acute kidney injury". Nature Reviews Nephrology. 7 (4): 189–200. doi:10.1038/nrneph.2011.16. ISSN 1759-507X. PMID 21364518. S2CID 32234965.
- Zuk, Anna; Bonventre, Joseph V. (2016-01-14). "Acute Kidney Injury". Annual Review of Medicine. 67 (1): 293–307. doi:10.1146/annurev-med-050214-013407. ISSN 0066-4219. PMC 4845743. PMID 26768243.
- Munshi, Raj; Hsu, Christine; Himmelfarb, Jonathan (2011-02-02). "Advances in understanding ischemic acute kidney injury". BMC Medicine. 9 (1): 11. doi:10.1186/1741-7015-9-11. ISSN 1741-7015. PMC 3038966. PMID 21288330.
- Kostandy, Botros B. (2012). "The role of glutamate in neuronal ischemic injury: the role of spark in fire". Neurol Sci. 33 (2): 223–237. doi:10.1007/s10072-011-0828-5. PMID 22044990. S2CID 18769752.
- Sims N.R.; Muyderman H. (2010). "Mitochondria, oxidative metabolism and cell death in stroke" (PDF). Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1802 (1): 80–91. doi:10.1016/j.bbadis.2009.09.003. PMID 19751827.
- Li, Yi-Heng; Ueng, Kwo-Chang; Jeng, Jiann-Shing; Charng, Min-Ji; Lin, Tsung-Hsien; Chien, Kuo-Liong; Wang, Chih-Yuan; Chao, Ting-Hsing; Liu, Ping-Yen (2017-04-01). "2017 Taiwan lipid guidelines for high risk patients". Journal of the Formosan Medical Association. 116 (4): 217–248. doi:10.1016/j.jfma.2016.11.013. ISSN 0929-6646. PMID 28242176.
- O'Brien, Emily C.; Greiner, Melissa A.; Xian, Ying; Fonarow, Gregg C.; Olson, DaiWai M.; Schwamm, Lee H.; Bhatt, Deepak L.; Smith, Eric E.; Maisch, Lesley (2015-10-13). "Clinical Effectiveness of Statin Therapy After Ischemic Stroke: Primary Results From the Statin Therapeutic Area of the Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) Study". Circulation. 132 (15): 1404–1413. doi:10.1161/CIRCULATIONAHA.115.016183. ISSN 0009-7322. PMID 26246175. S2CID 11252336.
- Infarct Combat Project website; accessed October 26, 2015.